BigHat Biosciences

BigHat Biosciences

BigHat Biosciences is a novel protein therapeutics company and developer of an AI-guided antibody design platform

Location
Roles tracked
0
In pipeline
0
Tracking since

At a glance

You're tracking 0 roles at BigHat Biosciences. Track a role to start building momentum here.

Company intel

From the job board · LinkedIn data via posting sync
Industry
Biotechnology Research
Company size
95 people
Headquarters
San Mateo, California
Founded
2019
Type
Privately Held
Total funding
$99.3M

BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases. BigHat is backed by Section 32, ‍Andreessen Horowitz, 8VC, Amgen Ventures, Bristol Myers Squibb, Quadrille, Grids Capital, AME Cloud Ventures, Innovation Endeavors and Gaingels.

Artificial Intelligence Biotechnology Medical Artificial Intelligence (AI) Therapeutics

Open roles at BigHat Biosciences